Company: IPODW
Filing Date: 2025-03-07
Form Type: S-1
Source: 0001213900-25-021721
Chunk: 3

Company: Dune Acquisition Corp II
Filing Date: 2025-03-07
Form: S-1
Chunk 3
---
, or Nasdaq, under the symbol “IPODU,” on or promptly after the date of this prospectus. We cannot guarantee that our securities will be approved for listing on Nasdaq. We expect the Class A ordinary shares and warrants comprising the units to begin separate trading on the 52 ndday following the date of this prospectus unless Clear Street LLC (“Clear Street”), the representative of the underwriters, informs us of its decision to allow earlier separate trading, subject to our satisfaction of certain conditions as described further herein. Once the securities comprising the units begin separate trading, we expect that the Class A ordinary shares and warrants will be listed on Nasdaq under the symbols “IPOD” and “IPODW,” respectively. We are an “emerging growth company” and a “smaller reporting company” under applicable federal securities laws and will be subject to reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See “ Risk Factors” beginning on page 51 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings. No offer or invitation, whether directly or indirectly, is being or may be made to the public in the Cayman Islands to subscribe for any of our securities.

|                                         |     | Per Unit |       |     | Total |             |
|:----------------------------------------|:----|:---------|------:|:----|:------|------------:|
| Public offering price(1):               |     | $        | 10.00 |     | $     | 150,000,000 |
| Underwriting discounts and commissions: |     | $        |  0.45 |     | $     |   6,750,000 |
| Proceeds, before expenses, to us:       |     | $        |  9.55 |     | $     | 143,250,000 |

_____________ (1)Includes (A) $00.05 per unit sold in the offering, or $750,000 in the aggregate, payable to the underwriters upon the closing of this offering (or $862,500 if the over -allotmentoption is exercised in full); and (B) up to $0.40 per unit, or up to $6,000,000 in the aggregate (or up to $6,900,000 if the overallotment option is exercised in full